Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7J8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,771
Award facts
- Contract value 100% obligated
- $13,771.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,771.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens (semaglutide injection), with an ultimate completion date of December 19, 2025. This non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for defense and civilian healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 through December 2026, designated as SPE2DX. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's receipt of this delivery order for Zepbound demonstrates its capability to fulfill federal procurement requirements for specialty pharmaceutical products through open competition and reflects the company's role as a key provider within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FM7J8?
SPE2DR26FM7J8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FM7J8 worth?
The government has obligated $13,771 on SPE2DR26FM7J8.
Is contract SPE2DR26FM7J8 an order under another contract?
Yes. SPE2DR26FM7J8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7J8 competed?
The extent of competition for SPE2DR26FM7J8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award